Based on the role of chloride transporters that regulate inhibitory synaptic plasticity mediated by the neurotransmitter GABA,38 we hypothesize that SLC12A5 maintains the function of GABA receptor through regulating Cl− gradient across the membrane in turn blocking neuronal excitability induced by glioma–neuron interactions. The gene discussed is SLC12A5; the disease is central nervous system cancer.